For Healthcare Professionals Only
Accredited Education for Advancing Clinical Practice
- Osteoporosis
- Rheumatology
- Gastroenterology
This collection of educational materials was independently developed by S. Karger Publishers Ltd. and made possible through an educational grant from Fresenius Kabi Swiss BioSim GmbH.
Comprehensive Osteoporosis Course
Our osteoporosis course provides a thorough, evidence-based overview of the disease, including identification, pharmacologic and non-pharmacologic treatment strategies, and patient management. It also covers the role of biosimilars in expanding access to care.
Fast Facts: Medical Management of Osteoporosis
Overview of the current therapeutic standards for the medical management of patients with osteoporosis in Europe.
IL-6 Receptor Inhibition Courses
Complementary modules focus on IL-6 receptor (IL-6R) inhibition and its therapeutic impact on conditions such as rheumatoid arthritis, giant cell arteritis, and juvenile idiopathic arthritis, where inflammation and bone loss often intersect.
Fast Facts: Interleukin-6 Receptor Inhibition in Rheumatoid Arthritis
Overview of the management of rheumatoid arthritis with interleukin-6 receptor inhibition therapy, with a specific focus on tocilizumab and its biosimilars.
Fast Facts: Interleukin-6 Receptor Inhibition in Giant Cell Arteritis
Overview of the management of giant cell arteritis with interleukin-6 receptor inhibition therapy, with a specific focus on tocilizumab and its biosimilars.
Fast Facts: Interleukin-6 Receptor Inhibition in Juvenile Idiopathic Arthritis
Overview of the management of juvenile idiopathic arthritis with interleukin-6 receptor inhibition therapy, with a specific focus on tocilizumab and its biosimilars.